SCHEMBL24251369

SCHEMBL24251369

Cc1nn2c(C(C)(C)C)c(C(=O)N[C@H]3CCc4ccccc43)ccc2c1-c1cccc(Cl)c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TAS1R3 Q7RTX0 8/20 0.45
▸ TAS1R1 Q7RTX1 8/20 0.45
▸ TAS1R2 Q8TE23 7/20 0.45
▸ PDE2A O00408 1/20 0.44
▸ CNR2 P34972 1/20 0.43
▸ CNR1 P21554 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ MAPK13 O15264 1/20 0.41
▸ MAPK12 P53778 1/20 0.41
▸ MAPK11 Q15759 1/20 0.41
▸ MAPK14 Q16539 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ KCNA5 P22460 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ CRHBP P24387 1/20 0.40
▸ CRHR2 Q13324 1/20 0.40
▸ SPR P35270 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24251368 0.87 TAS1R3 (0.45) TAS1R3TAS1R1TAS1R2PDE2ACNR2
SCHEMBL24251444 0.82 TAS1R3 (0.44) TAS1R3TAS1R1TAS1R2PDE2ACNR2
SCHEMBL24251362 0.76 BRD4 (0.40) TAS1R3TAS1R1TAS1R2
SCHEMBL24251415 0.74 TAS1R3 (0.46) TAS1R3TAS1R1TAS1R2PDE2ACNR2
SCHEMBL24251441 0.73 PDE2A (0.42) TAS1R3TAS1R1TAS1R2PDE2AALDH1A1
SCHEMBL24251550 0.73 PDE2A (0.42) TAS1R3TAS1R1TAS1R2PDE2AALDH1A1
SCHEMBL24251364 0.73 HSD17B2 (0.38) TAS1R3TAS1R1TAS1R2CNR2CNR1
SCHEMBL24251517 0.73 HSD17B2 (0.41) TAS1R3TAS1R1TAS1R2CNR2CNR1
SCHEMBL24251396 0.73 TAS1R3 (0.48) TAS1R3TAS1R1TAS1R2PDE2ACNR1
SCHEMBL24251374 0.72 TAS1R3 (0.49) TAS1R3TAS1R1TAS1R2PDE2ACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048903-A1 Anthelminthic Heterocyclic Compounds BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) 2022-02-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048903-A1 Anthelminthic Heterocyclic Compounds SDHA, PAH, PIGS TAS1R3 4103/4885TAS1R1 3604/4885TAS1R2 3646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback